Presentation and Outcomes of Hepatocellular Carcinoma in the Arabian Peninsula: A Review of a Single Institution Experience in the Sorafenib Era

被引：0
|
作者：
A. Shaaban
R. Salamah
Y. Abo Elseud
A. Mohanty
J. Albarrak
机构：
[1] Kuwait Cancer Control Centre,
[2] Minia University Hospital,undefined
来源：
Journal of Gastrointestinal Cancer | 2021年 / 52卷
关键词：
Hepatocellular carcinoma; Arabian Peninsula; Sorafenib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 89
页数：4
相关论文
共 50 条
  • [1] Presentation and Outcomes of Hepatocellular Carcinoma in the Arabian Peninsula: A Review of a Single Institution Experience in the Sorafenib Era
    Shaaban, A.
    Salamah, R.
    Abo Elseud, Y.
    Mohanty, A.
    Albarrak, J.
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (01) : 85 - 89
  • [2] Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature
    Xiong, Meng-Jun
    Patel, Chirag
    Manne, Upender
    Al Diffalha, Sameer
    HEPATIC ONCOLOGY, 2021, 8 (01)
  • [3] Cirrhotomimetic Hepatocellular Carcinoma: A Single Institution Experience
    Xiong, Meng-Jun
    Patel, Chirag
    Manne, Upender
    Al Diffalha, Sameer
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1559 - 1561
  • [4] Cirrhotomimetic Hepatocellular Carcinoma: A Single Institution Experience
    Xiong, Meng-Jun
    Patel, Chirag
    Manne, Upender
    Al Diffalha, Sameer
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1559 - 1561
  • [5] Hepatocellular carcinoma management in the era of sorafenib
    Rosmorduc, O.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 (04): : 327 - 333
  • [6] Sorafenib therapy for advanced hepatocellular carcinoma: a single centre experience
    Gill, Raghubinder S.
    Rodov, Marcia
    Mohsen, Waled
    Charlton, Barbara
    Moore, Barbara
    Koorey, David
    Bye, William
    Mccaughan, Geoffrey
    Bowen, David
    Prakoso, Emilia
    Shackel, Nicholas
    Strasser, Simone
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 75 - 76
  • [7] SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: EXPERIENCE IN SINGLE INSTITUTE
    Lee, S. S.
    Chang, H. M.
    Lee, J.
    Kim, T. W.
    Kim, K. M.
    Lee, H. C.
    Lee, Y. S.
    Suh, D. J.
    Lee, S. G.
    Kang, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 179 - 179
  • [8] Single-institution experience with sorafenib for hepatocellular carcinoma (HCC) in the post-liver transplant setting (Ltx)
    Mariano, Elizabeth Ann
    Bathini, Venu Gopal
    Barnard, Graham
    Anwar, Nadeem
    Bozorgzadeh, Adel
    Saidi, Reza
    Jabbour, Nicholas
    D'Antonio, Angela
    Barry, Curtis
    Switzer, Bradley Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [9] Patterns of presentation, referral, and treatment of hepatocellular carcinoma in a pre-sorafenib era: experience of a Canadian provincial cancer agency
    Sundaralingam, T.
    Gill, S.
    CURRENT ONCOLOGY, 2011, 18 (06) : E297 - E303
  • [10] Sorafenib: A Review in Hepatocellular Carcinoma
    Keating, Gillian M.
    TARGETED ONCOLOGY, 2017, 12 (02) : 243 - 253
12345